No.

Publication Date

Citing Article

1

2024

Yifan Hou, Zhenhua Zhao, Pan Li, Yujia Cao, Yi Zhang, Changsheng Guo, Xiaobo Nie, Junqing Hou. Combination therapies with Wnt signaling inhibition: A better choice for prostate cancer treatment, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024; 1879: 189186189186.  https://doi.org/10.1016/j.bbcan.2024.189186

2

2025

John T. Phoenix, Audris Budreika, Devin A. Schmeck, Raymond J. Kostlan, Marina G. Ferrari, Kristen S. Young, Charles S. Rogers, Carleen D. Deegan, Marcus W. Bienko, Hannah E. Bergom, Ella Boytim, Ryan M. Brown, Julia A. Walewicz, Shreya K. Bhagi, Leigh Ellis, Emmanuel S. Antonarakis, Justin M. Drake, Pushpinder S. Bawa, Jordan E. Vellky, Anthony Williams, Natalie M. Rezine, Jonathan P. Rennhack, Sean W. Fanning, Justin H. Hwang, Russell Z. Szmulewitz, Donald J. Vander Griend, Steven Kregel. 2025;   https://doi.org/10.1101/2025.07.18.664790

3

2026

Dongli Liu, Michelle Wong-Brown, Farhana Amy Sarker, Bayley Matthews, Jessica Morrison, Kristie-Ann Dickson, Amani Alghalayini, Jana Stojanova, King Man Wan, Jennifer Duggan, Christine Loo, Gill Stannard, Elyse Powell, Brigitte Hodder, Ellen Barlow, Deborah J. Marsh, Caroline E. Ford, Nikola A. Bowden. Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancer, Therapeutic Advances in Medical Oncology. 2026; 18: 17588359251409010.  https://doi.org/10.1177/17588359251409010

4

2024

Vignesh Sivaganesh, Tram M. Ta, Bela Peethambaran. Pentagalloyl Glucose (PGG) Exhibits Anti-Cancer Activity against Aggressive Prostate Cancer by Modulating the ROR1 Mediated AKT-GSK3β Pathway, International Journal of Molecular Sciences. 2024; 25: 7003.  https://doi.org/10.3390/ijms25137003

5

2025

Tao Yang, Jiahui Sun, Guolong Huang, Hong Wang, Zhexin He, Siying Lin, Yanjie Wang, Rongqiang Zhuang, Xianzhong Zhang, Hongwu Liu, Zhide Guo. 18F-/68Ga-Labeled Peptide-Based Probes for PET Imaging of ROR1 Expression, Journal of Medicinal Chemistry. 2025; 68: 26049.  https://doi.org/10.1021/acs.jmedchem.5c02016

6

2024

Lin Li, Weixue Huang, Xiaomei Ren, Zhen Wang, Ke Ding, Linxiang Zhao, Jinwei Zhang. Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies, Science China Life Sciences. 2024; 67: 2603.  https://doi.org/10.1007/s11427-024-2685-9

7

2025

Sara Soheili, Shekufe Rezghi Barez, Seyed Davar Siadat, Seyed Hossein Hejazi, Hamid Abtahi. In Silico and in vitro Characterization of Lactobacillus acidophilus Bacteriocins as ROR-1-Targeted Therapeutics in Breast Cancer, Iranian Journal of Pharmaceutical Research. 2025; 24:   https://doi.org/10.5812/ijpr-163509